Medicare Procedure and Patient Information
2012 Medicare Procedure Volume
Volume of procedures performed by Dr. Mohammad Houman Fekrazad, MD for Medicare patients.
| doctor visit | 309 |
|---|
(No ratings)
Dr. Mohammad Houman Fekrazad, MD is a medical oncologist in Valencia, CA specializing in medical oncology, adult oncology and adult hematology. Dr. Mohammad Houman Fekrazad, MD is affiliated with Antelope Valley Medical Center.
Volume of procedures performed by Dr. Mohammad Houman Fekrazad, MD for Medicare patients.
| doctor visit | 309 |
|---|
The top procedures that Dr. Mohammad Houman Fekrazad, MD treated as a medical oncologist in Valencia, CA during 2013 were hospital care and inpatient care.
Volume of procedures performed by Dr. Mohammad Houman Fekrazad, MD for Medicare patients.
| doctor visit | 407 |
|---|---|
| hospital care | 20 |
| inpatient care | 20 |
Information about Medicare patients treated by Dr. Mohammad Houman Fekrazad, MD.
| Male | 73 |
|---|---|
| Female | 72 |
| Non-Hispanic White | 74 |
|---|---|
| Black | 0 |
| Hispanic | 54 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 55 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 50 |
| Hypertension | 51 |
|---|---|
| High Cholesterol | 32 |
| Stroke | 0 |
| Ischemic Heart Disease | 26 |
| Depression | 32 |
| Chronic Kidney Disease | 17 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 8 |
| Heart Failure | 18 |
| Chronic Obstructive Pulmonary Disease | 17 |
| Diabetes | 23 |
| Dementia | 10 |
| Cancer | 40 |
The top procedures that Dr. Mohammad Houman Fekrazad, MD treated as a medical oncologist in Valencia, CA during 2014 were port flush, chemotherapy, biological response modifier (BRM) therapy and minimally invasive procedures.
Volume of procedures performed by Dr. Mohammad Houman Fekrazad, MD for Medicare patients.
| biological response modifier (BRM) therapy | 84 |
|---|---|
| chemotherapy | 84 |
| doctor visit | 451 |
| minimally invasive procedures | 84 |
| port flush | 94 |
Information about Medicare patients treated by Dr. Mohammad Houman Fekrazad, MD.
| Male | 119 |
|---|---|
| Female | 153 |
| Non-Hispanic White | 174 |
|---|---|
| Black | 30 |
| Hispanic | 50 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 111 |
|---|---|
| From 75 to 84 | 74 |
| 85 and over | 29 |
| Less than 65 | 58 |
| Hypertension | 61 |
|---|---|
| High Cholesterol | 45 |
| Stroke | 6 |
| Ischemic Heart Disease | 40 |
| Depression | 21 |
| Chronic Kidney Disease | 28 |
| Asthma | 8 |
| Osteoperosis | 9 |
| Atrial Fibrilation | 8 |
| Heart Failure | 20 |
| Chronic Obstructive Pulmonary Disease | 20 |
| Diabetes | 32 |
| Dementia | 10 |
| Cancer | 44 |
The top procedures that Dr. Mohammad Houman Fekrazad, MD treated as a medical oncologist in Valencia, CA during 2015 were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and port flush.
Volume of procedures performed by Dr. Mohammad Houman Fekrazad, MD for Medicare patients.
| biological response modifier (BRM) therapy | 289 |
|---|---|
| chemotherapy | 289 |
| doctor visit | 752 |
| hormone therapy | 35 |
| hospital care | 28 |
| inpatient care | 28 |
| minimally invasive procedures | 374 |
| port flush | 53 |
Information about Medicare patients treated by Dr. Mohammad Houman Fekrazad, MD.
| Male | 234 |
|---|---|
| Female | 250 |
| Non-Hispanic White | 354 |
|---|---|
| Black | 58 |
| Hispanic | 48 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 230 |
|---|---|
| From 75 to 84 | 132 |
| 85 and over | 52 |
| Less than 65 | 70 |
| Hypertension | 69 |
|---|---|
| High Cholesterol | 45 |
| Stroke | 8 |
| Ischemic Heart Disease | 45 |
| Depression | 18 |
| Chronic Kidney Disease | 33 |
| Asthma | 19 |
| Osteoperosis | 13 |
| Atrial Fibrilation | 12 |
| Heart Failure | 21 |
| Chronic Obstructive Pulmonary Disease | 29 |
| Diabetes | 34 |
| Dementia | 12 |
| Cancer | 49 |
The top procedures that Dr. Mohammad Houman Fekrazad, MD treated as a medical oncologist in Valencia, CA during 2016 were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and port flush.
Volume of procedures performed by Dr. Mohammad Houman Fekrazad, MD for Medicare patients.
| biological response modifier (BRM) therapy | 453 |
|---|---|
| chemotherapy | 453 |
| doctor visit | 1236 |
| hormone therapy | 93 |
| hospital care | 15 |
| inpatient care | 15 |
| minimally invasive procedures | 582 |
| port flush | 122 |
Information about Medicare patients treated by Dr. Mohammad Houman Fekrazad, MD.
| Male | 155 |
|---|---|
| Female | 177 |
| Non-Hispanic White | 235 |
|---|---|
| Black | 33 |
| Hispanic | 42 |
| Asian | 11 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 165 |
|---|---|
| From 75 to 84 | 94 |
| 85 and over | 26 |
| Less than 65 | 47 |
| Hypertension | 70 |
|---|---|
| High Cholesterol | 49 |
| Stroke | 7 |
| Ischemic Heart Disease | 50 |
| Depression | 22 |
| Chronic Kidney Disease | 40 |
| Asthma | 28 |
| Osteoperosis | 12 |
| Atrial Fibrilation | 10 |
| Heart Failure | 22 |
| Chronic Obstructive Pulmonary Disease | 28 |
| Diabetes | 33 |
| Dementia | 11 |
| Cancer | 52 |
The top procedures that Dr. Mohammad Houman Fekrazad, MD treated as a medical oncologist in Valencia, CA during 2017 were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and hormone therapy.
Volume of procedures performed by Dr. Mohammad Houman Fekrazad, MD for Medicare patients.
| biological response modifier (BRM) therapy | 226 |
|---|---|
| chemotherapy | 226 |
| doctor visit | 1031 |
| hormone therapy | 99 |
| hospital care | 61 |
| inpatient care | 61 |
| minimally invasive procedures | 308 |
| port flush | 86 |
Information about Medicare patients treated by Dr. Mohammad Houman Fekrazad, MD.
| Male | 193 |
|---|---|
| Female | 187 |
| Non-Hispanic White | 256 |
|---|---|
| Black | 41 |
| Hispanic | 51 |
| Asian | 17 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 169 |
|---|---|
| From 75 to 84 | 116 |
| 85 and over | 42 |
| Less than 65 | 53 |
| Hypertension | 73 |
|---|---|
| High Cholesterol | 47 |
| Stroke | 4 |
| Ischemic Heart Disease | 46 |
| Depression | 23 |
| Chronic Kidney Disease | 44 |
| Asthma | 8 |
| Osteoperosis | 10 |
| Atrial Fibrilation | 10 |
| Heart Failure | 23 |
| Chronic Obstructive Pulmonary Disease | 26 |
| Diabetes | 38 |
| Dementia | 11 |
| Cancer | 49 |
The top procedures that Dr. Mohammad Houman Fekrazad, MD treated as a medical oncologist in Valencia, CA during 2018 were hospital care, inpatient care, minimally invasive procedures and chemotherapy.
Volume of procedures performed by Dr. Mohammad Houman Fekrazad, MD for Medicare patients.
| biological response modifier (BRM) therapy | 232 |
|---|---|
| chemotherapy | 232 |
| doctor visit | 975 |
| hormone therapy | 76 |
| hospital care | 313 |
| inpatient care | 313 |
| minimally invasive procedures | 254 |
| port flush | 39 |
| urologic procedures | 26 |
Information about Medicare patients treated by Dr. Mohammad Houman Fekrazad, MD.
| Male | 206 |
|---|---|
| Female | 262 |
| Non-Hispanic White | 312 |
|---|---|
| Black | 46 |
| Hispanic | 67 |
| Asian | 31 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 201 |
|---|---|
| From 75 to 84 | 137 |
| 85 and over | 54 |
| Less than 65 | 76 |
| Hypertension | 75 |
|---|---|
| High Cholesterol | 54 |
| Stroke | 7 |
| Ischemic Heart Disease | 49 |
| Depression | 27 |
| Chronic Kidney Disease | 48 |
| Asthma | 11 |
| Osteoperosis | 12 |
| Atrial Fibrilation | 12 |
| Heart Failure | 34 |
| Chronic Obstructive Pulmonary Disease | 30 |
| Diabetes | 41 |
| Dementia | 18 |
| Cancer | 45 |
Information about Medicare patients treated by Dr. Mohammad Houman Fekrazad, MD.
| Male | 12 |
|---|---|
| Female | 12 |
| Non-Hispanic White | 0 |
|---|---|
| Black | 13 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| Hypertension | 50 |
|---|---|
| High Cholesterol | 0 |
| Stroke | 0 |
| Ischemic Heart Disease | 0 |
| Depression | 0 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 0 |
| Dementia | 0 |
| Cancer | 0 |
Volume of procedures performed by Dr. Mohammad Houman Fekrazad, MD for Medicare patients.
The highest averages for the top procedures that Dr. Mohammad Houman Fekrazad, MD treated as a medical oncologist in Valencia, CA were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and hospital care.
| biological response modifier (BRM) therapy | 256 |
|---|---|
| chemotherapy | 256 |
| doctor visit | 737 |
| hormone therapy | 75 |
| hospital care | 87 |
| inpatient care | 87 |
| minimally invasive procedures | 320 |
| urologic procedures | 26 |
Information about Medicare patients treated by Dr. Mohammad Houman Fekrazad, MD.
| Male | 124 |
|---|---|
| Female | 139 |
| Black / African American | 27 |
|---|---|
| Asian / Pacific Islander | 7 |
| Non-Hispanic White | 175 |
| Hispanic | 39 |
| Native American / Alaskan Native | 0 |
| Other | 0 |
| 75 to 84 | 69 |
|---|---|
| 85 and over | 25 |
| Less than 65 | 44 |
| 65 to 74 | 116 |
The highest averages of the most common conditions of Medicare patients that Dr. Mohammad Houman Fekrazad, MD treated were hypertension, cancer, high cholesterol and ischemic heart disease.
| Hypertension | 56 |
|---|---|
| High Cholesterol | 34 |
| Stroke | 4 |
| Ischemic Heart Disease | 32 |
| Depression | 17 |
| Chronic Kidney Disease | 26 |
| Asthma | 9 |
| Osteoporosis | 7 |
| Heart Failure | 17 |
| Chronic Obstructive Pulmonary Disease | 18 |
| Diabetes | 25 |
| Atrial Fibrillation | 7 |
| Cancer | 34 |
| Dementia | 9 |
He is certified by the Board Certification: Hematology and has a state license in New Mexico.
Board Certification: Board Certification: Hematology
Licensed In: New Mexico
Dr. Mohammad Houman Fekrazad, MD is associated with these hospitals and organizations:
Dr. Mohammad Houman Fekrazad, MD does not have any reviews yet, be the first to leave a review of Dr. Mohammad Houman Fekrazad, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Mohammad Houman Fekrazad, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Genentech USA, Inc. |
$54,894
Avastin $37,055 |
TARCEVA $15,648 |
TECENTRIQ $2,174 |
Alecensa $17 |
||
|---|---|---|---|---|---|---|
| Amgen Inc. |
$48,056
Kyprolis $44,980 |
Vectibix $51 |
XGEVA $25 |
$3,000 |
||
| Novartis Pharmaceuticals Corporation |
$253
SANDOSTATIN LAR $154 |
TAFINLAR $24 |
VOTRIENT $24 |
PROMACTA $23 |
TASIGNA $17 |
Other $11 |
| E.R. Squibb & Sons, L.L.C. |
$251
OPDIVO $134 |
ERBITUX $87 |
ELIQUIS $12 |
$18 |
||
| Merck Sharp & Dohme Corporation |
$90
KEYTRUDA $58 |
$33 |
||||
| Other |
$453
NINLARO $101 |
Lenvima $78 |
XTANDI $50 |
Gilotrif $41 |
LYNPARZA $36 |
Other $146 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $93,815 |
|---|---|
| Travel and Lodging | $6,230 |
| Food and Beverage | $3,937 |
| Education | $15 |
Dr. Mohammad Houman Fekrazad, MD has received 5 research payments totaling $12,556.
Dr. Mohammad Fekrazad's areas of specialization are adult hematology, adult oncology, and medical oncology; he sees patients in Valencia, CA and Lancaster, CA. Dr. Fekrazad is professionally affiliated with Antelope Valley Medical Center.